Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO

Gerhard Wingender1, Natalio Garbi, Beatrix Schumak

  • 1Institut für Molekulare Medizin und Experimentelle Immunologie, Bonn, Germany.

Insights

CpG oligonucleotides (CpG-ODN) can stimulate or suppress immune responses. Application site determines the effect: subcutaneous boosts immunity, while systemic application suppresses T cell activity via indoleamine 2,3-dioxygenase (IDO).

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • CpG-rich oligonucleotides (CpG-ODN) are known Toll-like receptor 9 (TLR9) agonists used as vaccine adjuvants.
  • Their immune-modulating effects are typically considered stimulatory.

Purpose of the Study:

  • To investigate the dual role of CpG-ODN as immune stimulators and suppressors.
  • To determine the influence of anatomical application site on CpG-ODN's immune effects.
  • To elucidate the mechanism underlying CpG-ODN-induced immune suppression.

Main Methods:

  • Administered antigen plus CpG-ODN subcutaneously and systemically in mice.
  • Assessed antigen-specific T cell activation in lymph nodes and spleen.
  • Measured CTL activity.
  • Investigated the role of indoleamine 2,3-dioxygenase (IDO) using 1-methyl-tryptophan (1-MT).
  • Utilized knockout mice lacking TLR9, type I, and type II interferons.

Main Results:

  • Subcutaneous application of CpG-ODN with antigen led to T cell activation in local lymph nodes.
  • Systemic application of CpG-ODN resulted in suppressed T cell expansion and CTL activity in the spleen.
  • CpG-ODN induced IDO expression in the spleen, and 1-MT abrogated the T cell suppression.
  • IDO expression was not observed in lymph nodes.
  • CpG-ODN-induced suppression was TLR9-dependent but independent of type I and II interferons.

Conclusions:

  • The route of administration is critical for the immune outcome of CpG-ODN application.
  • Systemic CpG-ODN can induce immune suppression mediated by IDO, primarily in the spleen.
  • CpG-ODN's potential for immune suppression could be harnessed for treating certain pathological conditions.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...